Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial

Author:

Batmunkh Tsetsegsaikhan,Moore Kerryn A.ORCID,Thomson Helen,Altangerel Bolor,Amraa Otgonjargal,Avaa Naranbaatar,Batbayar Lkhagvagaram,Batsukh Khishigjargal,Bright Kathryn,Burentogtokh Tsogjargal,Ha Do Lien Anh,Dorj Gantuya,Hart John D.ORCID,Javkhlantugs Khulan,Jigjidsuren Sarantsetseg,Justice Frances,Li Shuo,Licciardi Paul V.ORCID,Mashbaatar Khaliunaa,Mazarakis Nadia,Neal Eleanor F.G.,Nguyen Cattram Duong,Ochirbat Batbayar,Tsolmon Bilegtsaikhan,Tuya Alimaa,Surenjav Unursaikhan,von Mollendorf Claire,Mulholland KimORCID

Funder

State Government of Victoria

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Infectious Diseases,Psychiatry and Mental health,Geriatrics and Gerontology,Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Health Policy,Pediatrics, Perinatology and Child Health,Internal Medicine

Reference29 articles.

1. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID study;Menni;Lancet Infect Dis,2022

2. WHO SAGE roadmap for prioritizing uses of Covid-19 vaccines,2022

3. Good practice statement on the use of second booster doses for COVID-19 vaccines,2022

4. Comparative effectiveness of 3 or 4 doses of mRNA and inactivated whole-virus vaccines against COVID-19 infection, hospitalization and severe outcomes among elderly in Singapore;Tan;Lancet Reg Health West Pacific,2022

5. Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV- vaccinated individuals compared with homologous BNT162b2 vaccination: results of a pilot prospective cohort study from Lebanon;Moghnieh;Vaccine,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3